Jiesi Luo

1.3k total citations · 1 hit paper
55 papers, 993 citations indexed

About

Jiesi Luo is a scholar working on Molecular Biology, Computational Theory and Mathematics and Hematology. According to data from OpenAlex, Jiesi Luo has authored 55 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 8 papers in Computational Theory and Mathematics and 6 papers in Hematology. Recurrent topics in Jiesi Luo's work include Machine Learning in Bioinformatics (22 papers), RNA and protein synthesis mechanisms (13 papers) and Genomics and Phylogenetic Studies (9 papers). Jiesi Luo is often cited by papers focused on Machine Learning in Bioinformatics (22 papers), RNA and protein synthesis mechanisms (13 papers) and Genomics and Phylogenetic Studies (9 papers). Jiesi Luo collaborates with scholars based in China, United States and Hong Kong. Jiesi Luo's co-authors include Menglong Li, Xue Li, Yanzhi Guo, Lezheng Yu, Yizhou Li, Runyu Jing, Fengjuan Liu, Jianming Wu, Wei Chen and Xiaobo Zhou and has published in prestigious journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.

In The Last Decade

Jiesi Luo

52 papers receiving 984 citations

Hit Papers

Macrophage cell membrane-based nanoparticles: a new promi... 2022 2026 2023 2024 2022 50 100 150

Peers

Jiesi Luo
Christine Wurth Switzerland
Gisela Gabernet Switzerland
Anuradha Roy United States
Christine Wurth Switzerland
Jiesi Luo
Citations per year, relative to Jiesi Luo Jiesi Luo (= 1×) peers Christine Wurth

Countries citing papers authored by Jiesi Luo

Since Specialization
Citations

This map shows the geographic impact of Jiesi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiesi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiesi Luo more than expected).

Fields of papers citing papers by Jiesi Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiesi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiesi Luo. The network helps show where Jiesi Luo may publish in the future.

Co-authorship network of co-authors of Jiesi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jiesi Luo. A scholar is included among the top collaborators of Jiesi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiesi Luo. Jiesi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Lezheng, et al.. (2025). Multimodal deep learning for allergenic proteins prediction. BMC Biology. 23(1). 232–232.
2.
Zhang, Yonglin, Lezheng Yu, Li C. Xue, et al.. (2025). Optimizing lipocalin sequence classification with ensemble deep learning models. PLoS ONE. 20(4). e0319329–e0319329. 1 indexed citations
3.
Wang, Long, Qianhui Zhang, Ling Zhou, et al.. (2024). Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network. Pharmaceuticals. 17(1). 109–109. 4 indexed citations
4.
Tang, Xiaoqin, Rui Liao, Xiaogang Zhou, et al.. (2024). Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia. eLife. 13. 3 indexed citations
5.
Yang, Shuo, Jiesi Luo, Kui Cheng, et al.. (2024). Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway. Journal of Pharmaceutical Analysis. 15(1). 101054–101054.
6.
Tang, Xiaoqin, Rui Liao, Ling Zhou, et al.. (2024). Genistin: A Novel Estrogen Analogue Targeting ERβ to Alleviate Thrombocytopenia. International Journal of Biological Sciences. 20(6). 2236–2260. 9 indexed citations
7.
Luo, Jiesi, et al.. (2024). Development and validation of a predictive model for end-stage renal disease in systemic lupus erythematosus patients. Rheumatology International. 44(10). 1941–1958. 1 indexed citations
8.
Li, Xue, et al.. (2024). Machine learning to guide the use of plasma technology for antibiotic degradation. Journal of Hazardous Materials. 480. 135787–135787. 3 indexed citations
9.
Yu, Lezheng, Yonglin Zhang, Xue Li, et al.. (2023). EnsembleDL-ATG: Identifying autophagy proteins by integrating their sequence and evolutionary information using an ensemble deep learning framework. Computational and Structural Biotechnology Journal. 21. 4836–4848. 4 indexed citations
10.
Luo, Jiesi, et al.. (2023). Sequence-based malware detection using a single-bidirectional graph embedding and multi-task learning framework. Journal of Computer Security. 32(2). 141–163. 1 indexed citations
11.
Tang, Xiaoqin, Shuo Yang, Long Wang, et al.. (2023). Toll-like Receptors and Thrombopoiesis. International Journal of Molecular Sciences. 24(2). 1010–1010. 22 indexed citations
12.
Zhang, Ting, Nan Jiang, Yuesong Wu, et al.. (2023). The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-κB signaling. European Journal of Pharmacology. 944. 175604–175604. 6 indexed citations
13.
Wang, Long, Sha Liu, Jiesi Luo, et al.. (2022). Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia. Haematologica. 108(5). 1394–1411. 9 indexed citations
14.
Wu, Yuesong, Shengli Wan, Shuo Yang, et al.. (2022). Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment. Journal of Nanobiotechnology. 20(1). 542–542. 164 indexed citations breakdown →
15.
Zhang, Yonglin, et al.. (2021). Evaluation of deep learning approaches for modeling transcription factor sequence specificity. Genomics. 113(6). 3774–3781. 5 indexed citations
16.
Li, Zhong, et al.. (2020). ACNNT3: Attention-CNN Framework for Prediction of Sequence-Based Bacterial Type III Secreted Effectors. Computational and Mathematical Methods in Medicine. 2020. 1–7. 10 indexed citations
17.
Xu, Yungang, Yongcui Wang, Jiesi Luo, Weiling Zhao, & Xiaobo Zhou. (2017). Deep learning of the splicing (epi)genetic code reveals a novel candidate mechanism linking histone modifications to ESC fate decision. Nucleic Acids Research. 45(21). 12100–12112. 56 indexed citations
18.
Luo, Jiesi, Liang Liu, Suresh Venkateswaran, Qianqian Song, & Xiaobo Zhou. (2017). RPI-Bind: a structure-based method for accurate identification of RNA-protein binding sites. Scientific Reports. 7(1). 614–614. 22 indexed citations
19.
Guo, Yanzhi, Yuelong Wang, Jiesi Luo, et al.. (2015). Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder. Computational Biology and Chemistry. 56. 41–48. 12 indexed citations
20.
Luo, Jiesi, Zhongyu Liu, Yanzhi Guo, & Menglong Li. (2015). A structural dissection of large protein-protein crystal packing contacts. Scientific Reports. 5(1). 14214–14214. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026